TIDMAMS

RNS Number : 6515V

Advanced Medical Solutions Grp PLC

06 November 2017

 
 
     6 November 2017

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

PDMR Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that the Board, following a recommendation from the Remuneration Committee, has granted new share options to the following PDMR under the Advanced Medical Solutions Long Term Incentive Plan (the 'LTIP') on 2 November 2017. The vesting period of these options is subject to certain performance criteria over a three year period.

 
 PDMR           Options prior   Options granted   Resultant 
                 to grant                          holding 
=============  ==============  ================  ========== 
 Jeff Willis    122,594         9,308             131,902 
=============  ==============  ================  ========== 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ---------------------------------------------------------------- 
 a)   Name: Jeff Willis 
---  ---------------------------------------------------------------- 
 2.   Reason for the notification 
---  ---------------------------------------------------------------- 
 a)   Position/status: PDMR 
---  ---------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ---------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ---------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ---------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ---------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ---------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ---------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Grant of 9,308 options under the Advanced Medical 
                Solutions Long Term Incentive Plan on 2 November 2017 
---  ---------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)   Volume(s) 
       ---------  ---------- 
        n/a        n/a 
       ---------  ---------- 
---  ---------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  ---------------------------------------------------------------- 
 e)   Date of the transaction: 02/11/2017 
---  ---------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ----------------------------------------------------------------

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                  Tel: +44 (0) 
  plc                                               1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Chief Financial 
  Officer 
 
 Consilium Strategic Communications                Tel: +44 (0) 
                                                   20 3709 5700 
 Mary-Jane Elliott / Matthew Neal       AMS@consilium-comms.com 
  / Philippa Gardner / Rosie Phillips 
 
 Investec Bank PLC (NOMAD & Broker)                Tel: +44 (0) 
                                                   20 7597 5970 
 Daniel Adams / Gary Clarence 
  / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDMMGMGVMGNZM

(END) Dow Jones Newswires

November 06, 2017 05:45 ET (10:45 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.